These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
782 related items for PubMed ID: 10541333
1. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts. Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ. Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333 [Abstract] [Full Text] [Related]
2. Targeting strategies for cancer radiotherapy. Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT. Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342 [Abstract] [Full Text] [Related]
3. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Griffiths GL, Goldenberg DM, Knapp FF, Callahan AP, Chang CH, Hansen HJ. Cancer Res; 1991 Sep 01; 51(17):4594-602. PubMed ID: 1873804 [Abstract] [Full Text] [Related]
4. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies. Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A. J Nucl Med; 2001 Jan 01; 42(1):146-53. PubMed ID: 11197965 [Abstract] [Full Text] [Related]
6. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics. van Gog FB, Visser GW, Klok R, van der Schors R, Snow GB, van Dongen GA. J Nucl Med; 1996 Feb 01; 37(2):352-62. PubMed ID: 8667076 [Abstract] [Full Text] [Related]
11. Conjugation of unprotected trisuccin, N-[tris[2-[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocol. Safavy A, Sanders A, Qin H, Buchsbaum DJ. Bioconjug Chem; 1997 Feb 01; 8(5):766-71. PubMed ID: 9327144 [Abstract] [Full Text] [Related]
12. Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site. Ogawa K, Kawashima H, Kinuya S, Shiba K, Onoguchi M, Kimura H, Hashimoto K, Odani A, Saji H. Ann Nucl Med; 2009 Dec 01; 23(10):843-8. PubMed ID: 19921351 [Abstract] [Full Text] [Related]
13. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W. Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986 [Abstract] [Full Text] [Related]
14. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. J Nucl Med; 2004 Feb 01; 45(2):327-37. PubMed ID: 14960657 [Abstract] [Full Text] [Related]